Marion Mafham

16.4k total citations · 2 hit papers
33 papers, 1.1k citations indexed

About

Marion Mafham is a scholar working on Cardiology and Cardiovascular Medicine, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marion Mafham has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in General Health Professions and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marion Mafham's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Diabetes Treatment and Management (5 papers). Marion Mafham is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Diabetes Treatment and Management (5 papers). Marion Mafham collaborates with scholars based in United Kingdom, United States and New Zealand. Marion Mafham's co-authors include Jane Armitage, Martin Landray, Colin Baigent, Jonathan Emberson, Robert Clarke, Xu Lin, Derrick Bennett, Zhengming Chen, Rory Collins and Pang Yao and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Marion Mafham

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

2020 430 citations Marion Mafham, Enti Spata et al. The Lancet profile →
Vitamin D and Calcium for the Prevention of Fracture

2019 221 citations Marion Mafham, Jane Armitage et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marion Mafham United Kingdom	13	378	261	192	154	146	33	1.1k
Alfonso M. Cueto–Manzano Mexico	21	158 0.4×	191 0.7×	121 0.6×	32 0.2×	256 1.8×	100	1.6k
Francesc Fina Spain	15	189 0.5×	155 0.6×	154 0.8×	145 0.9×	167 1.1×	35	1.1k
Doug W Gould United Kingdom	20	144 0.4×	80 0.3×	66 0.3×	191 1.2×	179 1.2×	46	1.3k
Nasrollah Ghahramani United States	20	124 0.3×	77 0.3×	91 0.5×	168 1.1×	284 1.9×	102	1.6k
Trine Frøslev Denmark	18	174 0.5×	557 2.1×	83 0.4×	118 0.8×	364 2.5×	47	1.6k
Jason Nelson United States	20	73 0.2×	130 0.5×	76 0.4×	52 0.3×	157 1.1×	56	1.2k
Geetha Maddukuri United States	11	135 0.4×	155 0.6×	95 0.5×	211 1.4×	246 1.7×	14	1.5k
Teresa N. Harrison United States	21	70 0.2×	501 1.9×	140 0.7×	63 0.4×	186 1.3×	79	1.5k
Mario Saugo Italy	18	277 0.7×	262 1.0×	97 0.5×	26 0.2×	337 2.3×	53	1.2k
J. Michael Paterson Canada	19	116 0.3×	178 0.7×	93 0.5×	96 0.6×	512 3.5×	48	1.5k

Countries citing papers authored by Marion Mafham

Since Specialization

Citations

This map shows the geographic impact of Marion Mafham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Mafham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Mafham more than expected).

Fields of papers citing papers by Marion Mafham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Mafham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Mafham. The network helps show where Marion Mafham may publish in the future.

Co-authorship network of co-authors of Marion Mafham

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Mafham. A scholar is included among the top collaborators of Marion Mafham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Mafham. Marion Mafham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldacre, Raph, Jennifer C. E. Lane, Marion Mafham, et al.. (2025). Facilitating clinical trials in hip fracture in the UK. The Bone & Joint Journal. 107-B(2). 229–238.

Pessoa-Amorim, Guilherme, Raph Goldacre, Charles Crichton, et al.. (2024). Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England. Trials. 25(1). 429–429. 3 indexed citations

Petrucci, Giovanna, Georgina Buck, Bianca Rocca, et al.. (2024). Thromboxane biosynthesis and future events in diabetes: the ASCEND trial. European Heart Journal. 45(15). 1355–1367. 8 indexed citations

Camm, C Fielder, Parag Gajendragadkar, Guilherme Pessoa-Amorim, et al.. (2024). Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank. EP Europace. 27(2). 1 indexed citations

Haynes, Richard, Marion Mafham, Cheng‐Hock Toh, & Martin Landray. (2023). Delivering trials in the NHS: more than worth it. Clinical Medicine. 23(5). 525–526.

WILLIAMS, A., Gwyneth Davies, Amanda Farrin, et al.. (2023). A DELPHI study priority setting the remaining challenges for the use of routinely collected data in trials: COMORANT-UK. Trials. 24(1). 243–243. 2 indexed citations

Parish, Sarah, Georgina Buck, Theingi Aung, et al.. (2023). Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial. Trials. 24(1). 166–166. 3 indexed citations

Harper, Charlie, Marion Mafham, William G. Herrington, et al.. (2023). Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data. Heart. 109(19). 1467–1472. 5 indexed citations

Murray, Macey L., Sharon Love, James R. Carpenter, et al.. (2022). Data provenance and integrity of health-care systems data for clinical trials. The Lancet Digital Health. 4(8). e567–e568. 6 indexed citations

10.

Suvarna, S K, Guy N. Rutty, Anna Green, et al.. (2022). Coronial postmortem reports and indirect COVID-19 pandemic-related mortality. Journal of Clinical Pathology. 76(7). 457–462. 2 indexed citations

11.

Arnold, Matthew, Alison Offer, Marion Mafham, et al.. (2021). A Biomarker-based Biological Age in UK Biobank: Composition and Prediction of Mortality and Hospital Admissions. The Journals of Gerontology Series A. 76(7). 1295–1302. 35 indexed citations

12.

Wu, Jianhua, Marion Mafham, Mamas A. Mamas, et al.. (2021). Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020. Mayo Clinic Proceedings. 96(4). 952–963. 41 indexed citations

13.

Pessoa-Amorim, Guilherme, Mark Campbell, Lucy Fletcher, et al.. (2021). Making trials part of good clinical care: lessons from the RECOVERY trial. Future Healthcare Journal. 8(2). e243–e250. 31 indexed citations

14.

Casadei, Barbara, Marion Mafham, Enti Spata, et al.. (2020). Impact of the COVID-19 pandemic on admission rates for, and management of, acute coronary syndromes in England.. The Lancet. 2 indexed citations

15.

Mafham, Marion, Enti Spata, Raph Goldacre, et al.. (2020). COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. The Lancet. 396(10248). 381–389. 430 indexed citations breakdown →

16.

Mafham, Marion, Louise Bowman, Richard Haynes, & Jane Armitage. (2019). Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study. Diabetologia. 63(5). 898–905. 5 indexed citations

17.

Bowman, Louise, Marion Mafham, Karl Wallendszus, et al.. (2018). Effects of aspirin for primary prevention in persons with diabetes mellitus: the ASCEND Study Collaborative Group. Journal of Vascular Surgery. 69(1). 305–305. 21 indexed citations

18.

Mafham, Marion, Natalie Staplin, Jonathan Emberson, et al.. (2016). Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection. Nephrology Dialysis Transplantation. 33(2). 257–264. 8 indexed citations

19.

Mafham, Marion, Jonathan Emberson, Martin Landray, Chi Pang Wen, & Colin Baigent. (2011). Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis. PLoS ONE. 6(10). e25920–e25920. 51 indexed citations

20.

Mafham, Marion, Jeffrey Barron, Jonathan Emberson, et al.. (2007). A Practical Method of Measuring Glomerular Filtration Rate by Iohexol Clearance Using Dried Capillary Blood Spots. Nephron Clinical Practice. 106(3). c104–c112. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact